Emerging Growth Reports
ZenaTech (NASDAQ: ZENA) Reports Record 558% Year-Over-Year Revenue Growth to...
Total assets grew 188% to $99.8 million; DaaS segment delivered over $10 million in first full year of operations Miami, FL–(Emerging Growth Newswire –...
SBC Medical Group Holdings, Inc. (NASDAQ: SBC) Emerging Growth Research...
Stay on Target: Long-term accomplished founder and management have shepherded SBC from a solo clinic in 2000 to become a global cosmetic treatment center...
Immuron Limited (NASDAQ: IMRN) (ASX: IMC) Emerging Growth Research Report...
Immuron reported solid revenue growth for the third quarter of its 2026 fiscal year, ended March 31, 2026. Global sales were AUD $1.5 million,...
First Phosphate Corp. (OTCQX: FRSPF) (CSE: PHOS) Emerging Growth Research...
First Phosphate Completes Drill Programme First Phosphate (PHOS) has completed the 40,000-meter drill program at its Bégin-Lamarche Property, located in Saguenay-Lac-St-Jean, Quebec, Canada. This infill...
CopAur Minerals Inc. (TSXV: CPAU) (OTCQB: COPAF) Emerging Growth Research...
Near-Term Gold Production in Nevada’s Kinsley Mountain, Initiate with a Buy Rating. CopAur Minerals Inc. (TSX-V: CPAU) is a gold-focused exploration and development company,...
SBC Medical Group Holdings, Inc. (NASDAQ: SBC) Emerging Growth Research Report – April 6, 2026
Return to Growth in 2026: Long-term accomplished founder and management have shepherded SBC from a solo clinic in 2000 to become a global cosmetic treatment center...
OSR Holdings, Inc. (NASDAQ: OSRH) Emerging Growth Research Report – March 26, 2026
2nd Materially Positive Event in Recent Months: OSRH announced global interest to license/distribute its Woori IO non-invasive glucose monitor. Of note, an NDA has been signed...
Virtuix Holdings Inc. (NASDAQ: VTIX) Emerging Growth Research Report – March 6, 2026
Virtuix Holdings Inc. (VTIX) announced pleasing fiscal Q3:26 earnings, but shares sold off following its circa +60% price rise off lows. Trailing nine-month revenue through Dec-2024...
Immuron Limited (NASDAQ: IMRN) (ASX: IMC) Emerging Growth Research Report – March 5, 2026
Immuron Reports 1H 2026 Financial Results and Announces a Strategic Reset. Immuron reported solid revenue growth for the first half of its 2026 fiscal year, ended...
Immuron Limited (NASDAQ: IMRN) (ASX: IMC) Emerging Growth Research Report – January 22, 2026
Immuron Reports Steady Sales Growth for Travelan®, Its OTC Immune Supplement. Immuron announced solid revenue growth for the first half of its 2026 fiscal year, ending...